GENEVA, Sept. 21 -- INVENTIVA (50 rue de Dijon21121 DAIX) filed a patent application (PCT/EP2025/056997) for "PREVENTION OF BLOOD DISORDERS IN PATIENT TREATED WITH A PPAR AGONIST" on Mar 14, 2025. With publication no. WO/2025/191117, the details related to the patent application was published on Sep 18, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HUOT-MARCHAND, Philippe (50 rue de Dijon21121 DAIX), BROQUA, Pierre (50 rue de Dijon21121 DAIX), PATEL, Sanjaykumar (50 rue de Dijon21121 DAIX)
Abstract:
The present invention relates to the use of sodium glucose transporter 2 (SGLT2) inhibit...